OrthoPediatrics (KIDS)
(Delayed Data from NSDQ)
$31.95 USD
+0.73 (2.34%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $31.96 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth B Momentum D VGM
Income Statements
Fiscal Year end for OrthoPediatrics Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 149 | 122 | 98 | 71 | 73 |
Cost Of Goods | 37 | 32 | 25 | 16 | 18 |
Gross Profit | 111 | 91 | 73 | 55 | 55 |
Selling & Adminstrative & Depr. & Amort Expenses | 138 | 116 | 91 | 82 | 64 |
Income After Depreciation & Amortization | -27 | -25 | -18 | -27 | -9 |
Non-Operating Income | 5 | 24 | 3 | -4 | 0 |
Interest Expense | 0 | 2 | 2 | 3 | 4 |
Pretax Income | -21 | -4 | -17 | -34 | -13 |
Income Taxes | 0 | -5 | -1 | -1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -21 | 1 | -16 | -33 | -13 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | -1 |
Net Income (GAAP) | -21 | 1 | -16 | -33 | -14 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -8 | -9 | -7 | -19 | -4 |
Depreciation & Amortization (Cash Flow) | 18 | 17 | 11 | 8 | 5 |
Income After Depreciation & Amortization | -27 | -25 | -18 | -27 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 22.68 | 20.95 | 19.27 | 18.06 | 14.62 |
Diluted EPS Before Non-Recurring Items | -0.85 | -0.82 | -0.75 | -1.27 | -0.87 |
Diluted Net EPS (GAAP) | -0.92 | 0.06 | -0.84 | -1.82 | -0.94 |
Fiscal Year end for OrthoPediatrics Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 52.80 | 44.69 | 37.61 | 39.97 | 39.56 |
Cost Of Goods | 12.00 | 12.51 | 10.90 | 9.02 | 9.53 |
Gross Profit | 40.80 | 32.17 | 26.71 | 30.95 | 30.03 |
SG&A, R&D, and Dept/Amort Expenses | 46.46 | 41.90 | 34.78 | 35.47 | 35.61 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.66 | -9.73 | -8.07 | -4.52 | -5.58 |
Non-Operating Income | -0.12 | 0.02 | 0.86 | 0.79 | 2.59 |
Interest Expense | 0.26 | 0.64 | -0.30 | 0.02 | 0.29 |
Pretax Income | -6.05 | -10.34 | -6.90 | -3.74 | -3.29 |
Income Taxes | -0.02 | -2.53 | -0.21 | 0.85 | -0.40 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -6.03 | -7.81 | -6.69 | -4.59 | -2.89 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.03 | -7.81 | -6.69 | -4.59 | -2.89 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 23.15 | 22.82 | 22.76 | 22.76 | 22.71 |
Diluted EPS Before Non-Recurring Items | -0.23 | -0.30 | -0.23 | -0.13 | -0.19 |
Diluted Net EPS (GAAP) | -0.26 | -0.34 | -0.29 | -0.20 | -0.13 |